{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:29:52Z","timestamp":1794637792210,"version":"4.9.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Methylxanthines (caffeine; aminophylline\/theophylline) are commonly used for apnea of prematurity (AOP) treatment. We aimed to compare the efficacy and adverse effects of caffeine and aminophylline\/theophylline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective case\u2013control gestational age-matched study investigates patients born between January 2017 and December 2018, 23\u201335 weeks gestation with birth weights &amp;gt;500 g treating AOP with caffeine or aminophylline\/theophylline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 144 cases (48 in caffeine group and 96 in aminophylline\/theophylline group). The median treatment durations were 11 and 17 days in caffeine and aminophylline\/theophyllinegroup (<jats:italic>p<\/jats:italic> = 0.002). When tachycardia is defined as heart rate \u2265160 bpm, the rates were 8.3 and 34.4% in caffeine and control group (<jats:italic>p<\/jats:italic> = 0.001). When tachycardia is defined as 10 bpm over baseline heart rate, the rates were 41.7 and 63.5% in caffeine and aminophylline\/theophylline group (<jats:italic>p<\/jats:italic> = 0.01). Stratified by gestational age and sex, significant reductions in tachycardia rates with caffeine than with theophylline were limited to male infants and infants born at &amp;lt;30 weeks gestation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>For apnea treatment, caffeine has greater efficacy and fewer tachycardia than aminophylline\/theophylline, especially in male infants and infants born at &amp;lt;30 weeks gestation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.817624","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:46:11Z","timestamp":1645685171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Specific Premature Groups Have Better Benefits When Treating Apnea With Caffeine Than Aminophylline\/Theophylline"],"prefix":"10.3389","volume":"10","author":[{"given":"Yi-Chieh","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-An","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Nien","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chieh","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/jp.2010.126","article-title":"Apnea of prematurity: pathogenesis and management strategies","volume":"31","author":"Mathew","year":"2011","journal-title":"J Perinatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD000273","DOI":"10.1002\/14651858.CD000273.pub2","article-title":"Caffeine versus theophylline for apnea in preterm infants","volume":"2010","author":"Henderson-Smart","year":"2010","journal-title":"Cochrane Database Syst Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s00383-003-0968-7","article-title":"Return of the milk curd syndrome","volume":"19","author":"Flikweert","year":"2003","journal-title":"Pediatr Surg Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5863\/1551-6776-18.1.45","article-title":"Apnea of prematurity: caffeine dose optimization","volume":"18","author":"Francart","year":"2013","journal-title":"J Pediatr Pharmacol Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5385\/nm.2015.22.1.14","article-title":"Comparison between caffeine and theophylline therapy for apnea of prematurity","volume":"22","author":"Jeong","year":"2015","journal-title":"Neonat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1542\/peds.2015-3757","article-title":"Apnea of prematurity","author":"Eichenwald","year":"2016","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/000992280003900602","article-title":"Current options in the management of apnea of prematurity","volume":"39","author":"Bhatia","year":"2000","journal-title":"Clin Pediatr (Phila)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/14767058.2010.517704","article-title":"Caffeine impact on neonatal morbidities","volume":"23","author":"Aranda","year":"2010","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","article-title":"A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity","volume":"157","author":"Di Fiore","year":"2010","journal-title":"J Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.jp.7211182","article-title":"Apnea is associated with neurodevelopmental impairment in very low birth weight infants","volume":"24","author":"Janvier","year":"2004","journal-title":"J Perinatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/j.1651-2227.2008.00989.x","article-title":"A preliminary report of nursing in the three-stair-position to prevent apnoea of prematurity","volume":"97","author":"Bauschatz","year":"2008","journal-title":"Acta Paediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-3476(85)80475-3","article-title":"Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants","volume":"106","author":"Miller","year":"1985","journal-title":"J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.clp.2021.07.008","article-title":"Synchronized invasive mechanical ventilation","volume":"48","author":"Bresesti","year":"2021","journal-title":"Clin Perinatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S377","DOI":"10.1016\/S1526-0542(04)90067-X","article-title":"Apnoea of prematurity","volume":"5","author":"Martin","year":"2004","journal-title":"Paediatr Respir Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1056\/NEJMe068028","article-title":"Caffeine for apnea of prematurity","volume":"354","author":"Bancalari","year":"2006","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bpa.2010.04.002","article-title":"Neonatal apnoea","volume":"24","author":"Sale","year":"2010","journal-title":"Best Pract Res Clin Anaesthesiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"Cd000140","DOI":"10.1002\/14651858.CD000140","article-title":"Methylxanthine treatment for apnea in preterm infants","volume":"2001","author":"Henderson-Smart","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","article-title":"Caffeine therapy for apnea of prematurity","volume":"354","author":"Schmidt","year":"2006","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.inhe.2009.09.005","article-title":"Caffeine for the management of apnea in preterm infants","volume":"1","author":"Mueni","year":"2009","journal-title":"Int Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41390-018-0089-6","article-title":"Caffeine: an evidence-based success story in VLBW pharmacotherapy","volume":"84","author":"Dobson","year":"2018","journal-title":"Pediatr Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40272-013-0063-z","article-title":"Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity","volume":"16","author":"Schoen","year":"2014","journal-title":"Paediatr Drugs."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.7499\/j.issn.1008-8830.2014.11.012","volume":"16","author":"Xu","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jpeds.2017.09.032","article-title":"Caffeine therapy-when and why?","volume":"190","author":"Jobe","year":"2017","journal-title":"J Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0022-3476(87)80569-3","article-title":"Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant","volume":"110","author":"Bairam","year":"1987","journal-title":"J Pediatr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/adc.67.4_Spec_No.425","article-title":"Caffeine or theophylline for neonatal apnoea?","volume":"67","author":"Scanlon","year":"1992","journal-title":"Arch Dis Child."},{"key":"B26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1440-1754.2009.01570.x","article-title":"Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial","volume":"45","author":"Skouroliakou","year":"2009","journal-title":"J Paediatr Child Health."},{"key":"B27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13312-017-1088-0","article-title":"Comparative efficacy and safety of caffeine and aminophylline for apnea of prematurity in preterm (< \/=34 weeks) neonates: a randomized controlled trial","volume":"54","author":"Shivakumar","year":"2017","journal-title":"Indian Pediatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12669\/pjms.35.1.94","article-title":"Comparison of caffeine versus theophylline for apnea of prematurity","volume":"35","author":"Zulqarnain","year":"2019","journal-title":"Pak J Med Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12098-008-0008-7","article-title":"Apnea in the newborn","volume":"75","author":"Mishra","year":"2008","journal-title":"Indian J Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2165\/00128072-200305030-00006","article-title":"Treatment of apnea of prematurity","volume":"5","author":"Bhatt-Mehta","year":"2003","journal-title":"Paediatr Drugs."},{"key":"B32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ppul.20832","article-title":"Neonatal apnea: what's new?","volume":"43","author":"Abu-Shaweesh","year":"2008","journal-title":"Pediatr Pulmonol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/archpedi.1985.02140090060028","article-title":"Comparative efficacy of theophylline and caffeine in the treatment of idiopathic apnea in premature infants","volume":"139","author":"Brouard","year":"1985","journal-title":"Am J Dis Child."},{"key":"B34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1248\/yakushi.17-00144","volume":"138","author":"Nagasato","year":"2018","journal-title":"Yakugaku Zasshi."},{"key":"B35","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1177\/00912700122010500","article-title":"Caffeine metabolism in premature infants","volume":"41","author":"Al-Alaiyan","year":"2001","journal-title":"J Clin Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00002018-200023050-00002","article-title":"Risks and benefits of therapies for apnoea in premature infants","volume":"23","author":"Hascoet","year":"2000","journal-title":"Drug Saf."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.817624\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:46:15Z","timestamp":1645685175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.817624\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":36,"alternative-id":["10.3389\/fped.2022.817624"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.817624","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"article-number":"817624"}}